These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26497060)

  • 1. Profiles of responses of immunological factors to different subtypes of Kawasaki disease.
    Ding Y; Li G; Xiong LJ; Yin W; Liu J; Liu F; Wang RG; Xia K; Zhang SL; Zhao L
    BMC Musculoskelet Disord; 2015 Oct; 16():315. PubMed ID: 26497060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.
    Xu M; Jiang Y; Wang J; Liu J; Liu C; Liu D; Yang S
    BMC Immunol; 2019 Jun; 20(1):16. PubMed ID: 31159728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kawasaki disease. Immunological evaluation of 26 cases].
    Krasovec S; Bezrodnik L; Gaillard MI; Carabajal P; Ginaca A; Vainstein E
    Medicina (B Aires); 2001; 61(1):8-14. PubMed ID: 11265631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble CD4 and CD8 levels in Kawasaki disease.
    Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
    Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease.
    Shingadia D; O'Gorman M; Rowley AH; Shulman ST
    Pediatr Res; 2001 Oct; 50(4):538-43. PubMed ID: 11568300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease.
    Reichardt P; Lehmann I; Sierig G; Borte M
    Infection; 2002 Dec; 30(6):360-4. PubMed ID: 12478326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum soluble CD4 and CD8 levels in Kawasaki disease].
    Motohashi T
    Arerugi; 1992 Feb; 41(2 Pt 1):140-7. PubMed ID: 1567283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease.
    Lee HK; Kim DS; Noh GW; Lee KY
    Yonsei Med J; 1996 Oct; 37(5):357-63. PubMed ID: 8997168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations in Kawasaki disease.
    Shannon K; Fink CW; Buchanan GR; Punaro M; Stastny P
    Clin Exp Rheumatol; 1983; 1(1):59-62. PubMed ID: 6398155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of lymphocyte subsets, immunoglobulins, and complement C3 and C4 in children with hand-foot-mouth disease].
    Liu XM; Cui ZZ; Jing SJ; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1203-1207. PubMed ID: 31874660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
    Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
    Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic abnormalities in children with acute Kawasaki disease.
    Ding XT; Yang XQ; Li CR; Shen J
    Chin Med J (Engl); 1993 Sep; 106(9):688-92. PubMed ID: 8287706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
    Ehara H; Kiyohara K; Izumisawa Y; Ito T
    Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children.
    Engelberg R; Martin M; Wrotniak BH; Hicar MD
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):32. PubMed ID: 28427414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.